Interlife Holdings Co., Ltd. (TYO:1418)
Japan · Delayed Price · Currency is JPY 561.00
-5.00 (-0.88%)
Apr 16, 2026, 3:30 PM JST
Interlife Holdings Revenue
In the fiscal year ending February 28, 2026, Interlife Holdings had annual revenue of 16.34B JPY, down -3.57%. Interlife Holdings had revenue of 3.94B in the quarter ending February 28, 2026, with 2.13% growth.
Revenue
16.34B
Revenue Growth
-3.57%
P/S Ratio
0.53
Revenue / Employee
64.06M
Employees
255
Market Cap
8.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2026 | 16.34B | -604.00M | -3.57% |
| Feb 28, 2025 | 16.94B | 4.31B | 34.17% |
| Feb 29, 2024 | 12.63B | 1.17B | 10.17% |
| Feb 28, 2023 | 11.46B | -334.00M | -2.83% |
| Feb 28, 2022 | 11.79B | -3.03B | -20.43% |
| Feb 28, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dynic | 44.33B |
| Harima B.Stem | 29.96B |
| Kufu Company Holdings | 13.84B |
| Frontier Management | 13.49B |
| EnBio Holdings | 11.58B |
| IFIS Japan | 6.96B |
| Hikari Business Form | 6.83B |
| GMO Product Platform | 6.82B |